Correction: Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1 (Leukemia, (2019), 33, 8, (1910-1922), 10.1038/s41375-019-0413-0)

  1. Pfeifer, H.
  2. Cazzaniga, G.
  3. van der Velden, V.H.J.
  4. Cayuela, J.M.
  5. Schäfer, B.
  6. Spinelli, O.
  7. Akiki, S.
  8. Avigad, S.
  9. Bendit, I.
  10. Borg, K.
  11. Cavé, H.
  12. Elia, L.
  13. Reshmi, S.C.
  14. Gerrard, G.
  15. Hayette, S.
  16. Hermanson, M.
  17. Juh, A.
  18. Jurcek, T.
  19. Chillón, M.C.
  20. Homburg, C.
  21. Martinelli, G.
  22. Kairisto, V.
  23. Lange, T.
  24. Lion, T.
  25. Mueller, M.C.
  26. Pane, F.
  27. Rai, L.
  28. Damm-Welk, C.
  29. Sacha, T.
  30. Schnittger, S.
  31. Touloumenidou, T.
  32. Valerhaugen, H.
  33. Vandenberghe, P.
  34. Zuna, J.
  35. Serve, H.
  36. Herrmann, E.
  37. Markovic, S.
  38. van Dongen, J.J.M.
  39. Ottmann, O.G.
  40. Erakutsi egile guztiak +
Aldizkaria:
Leukemia

ISSN: 1476-5551,  0887-6924

Argitalpen urtea: 2020

Alea: 34

Zenbakia: 7

Orrialdeak: 1970

Mota: Hutsen zuzenketa

DOI: 10.1038/S41375-020-0707-2 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus